ATOGEPANT

N/A

Manufactured by AbbVie Inc.

9,899 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ATOGEPANT

ATOGEPANT is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AbbVie Inc.. The most commonly reported adverse reactions for ATOGEPANT include MIGRAINE, DRUG INEFFECTIVE, HEADACHE, NAUSEA, CONSTIPATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ATOGEPANT.

Top Adverse Reactions

MIGRAINE1,057 reports
DRUG INEFFECTIVE743 reports
HEADACHE599 reports
NAUSEA560 reports
CONSTIPATION418 reports
FATIGUE390 reports
DIZZINESS246 reports
THERAPY INTERRUPTED186 reports
DECREASED APPETITE162 reports
OFF LABEL USE160 reports
PAIN152 reports
VOMITING148 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE140 reports
ANXIETY129 reports
WEIGHT DECREASED129 reports
COVID 19126 reports
SOMNOLENCE126 reports
FEELING ABNORMAL123 reports
ALOPECIA109 reports
INSOMNIA106 reports
PRODUCT DOSE OMISSION ISSUE103 reports
PRODUCT USE ISSUE102 reports
DYSPNOEA101 reports
DIARRHOEA98 reports
MALAISE97 reports
ABDOMINAL PAIN UPPER95 reports
PRURITUS95 reports
DEPRESSION92 reports
SEIZURE89 reports
RASH88 reports
SURGERY78 reports
FALL73 reports
ILLNESS73 reports
ARTHRALGIA71 reports
SUICIDAL IDEATION69 reports
PALPITATIONS68 reports
ASTHENIA67 reports
CEREBROVASCULAR ACCIDENT67 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS66 reports
HYPERTENSION59 reports
MEMORY IMPAIRMENT59 reports
ABDOMINAL DISCOMFORT57 reports
LOSS OF CONSCIOUSNESS57 reports
ADVERSE DRUG REACTION56 reports
HYPOAESTHESIA56 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION56 reports
CHEST PAIN55 reports
ABDOMINAL PAIN54 reports
HYPERSENSITIVITY54 reports
PARAESTHESIA53 reports
BACK PAIN51 reports
PAIN IN EXTREMITY51 reports
TREMOR51 reports
COUGH50 reports
THERAPEUTIC PRODUCT EFFECT DECREASED48 reports
ABDOMINAL DISTENSION47 reports
VERTIGO47 reports
THERAPEUTIC RESPONSE SHORTENED46 reports
VISION BLURRED46 reports
BRAIN FOG43 reports
DYSPEPSIA43 reports
GASTROINTESTINAL DISORDER43 reports
CONDITION AGGRAVATED42 reports
MUSCLE SPASMS42 reports
BLOOD PRESSURE INCREASED41 reports
NASOPHARYNGITIS41 reports
TINNITUS41 reports
SINUSITIS39 reports
DEATH38 reports
PYREXIA38 reports
STRESS38 reports
URTICARIA38 reports
NECK PAIN37 reports
ADVERSE EVENT36 reports
DRUG HYPERSENSITIVITY36 reports
SPINAL OPERATION36 reports
UNEVALUABLE EVENT36 reports
VISUAL IMPAIRMENT36 reports
HEART RATE INCREASED35 reports
WEIGHT INCREASED35 reports
EYE PAIN34 reports
NEPHROLITHIASIS34 reports
THERAPEUTIC RESPONSE DECREASED34 reports
CHEST DISCOMFORT33 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES33 reports
PNEUMONIA33 reports
DISTURBANCE IN ATTENTION32 reports
HYPOTENSION32 reports
PRODUCT USE IN UNAPPROVED INDICATION32 reports
BALANCE DISORDER31 reports
DRY MOUTH31 reports
GAIT DISTURBANCE31 reports
INFLUENZA31 reports
ASTHMA30 reports
GASTROOESOPHAGEAL REFLUX DISEASE30 reports
INCORRECT DOSE ADMINISTERED30 reports
INJECTION SITE PAIN30 reports
INTENTIONAL PRODUCT MISUSE30 reports
NASAL CONGESTION30 reports
URINARY TRACT INFECTION30 reports

Report Outcomes

Out of 5,787 classified reports for ATOGEPANT:

Serious 32.0%Non-Serious 68.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female4,352 (86.3%)
Male685 (13.6%)
Unknown4 (0.1%)

Reports by Age

Age 4566 reports
Age 5462 reports
Age 4460 reports
Age 4760 reports
Age 5360 reports
Age 5959 reports
Age 4958 reports
Age 4255 reports
Age 4153 reports
Age 6253 reports
Age 5152 reports
Age 6052 reports
Age 5651 reports
Age 5751 reports
Age 5050 reports
Age 5549 reports
Age 3448 reports
Age 5848 reports
Age 4844 reports
Age 5244 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ATOGEPANT?

This profile reflects 9,899 FDA FAERS reports that mention ATOGEPANT. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ATOGEPANT?

Frequently reported terms in FAERS include MIGRAINE, DRUG INEFFECTIVE, HEADACHE, NAUSEA, CONSTIPATION, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ATOGEPANT?

Labeling and FAERS entries often list AbbVie Inc. in connection with ATOGEPANT. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.